A Day Up For MiNK Therapeutics, Inc.

Fri, Jul 11, 2025 at 07:22 PM

MiNK Therapeutics, Inc. (INKT:NASDAQ) rocketted at $64.17, a gain of 730.1%. On Fri, Jul 11, 2025, INKT:NASDAQ hit a New 2-Week High of $64.17. The stock appeared on our News Catalysts scanner on Fri, Jul 11, 2025 at 08:53 AM in the 'BIOTECH' category. From Fri, Jun 27, 2025, the stock recorded 66.67% Up Days and 40.00% Green Days

About MiNK Therapeutics, Inc. (INKT:NASDAQ)

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other life-threatening...

Top 10 Gainers:

MiNK Therapeutics, Inc. (INKT:NASDAQ), 730.14%
Smart for Life, Inc. (SMFL:NASDAQ), 500%
Hempacco Co., Inc. (HPCO:NASDAQ), 250%
Future FinTech Group Inc. (FTFT:NASDAQ), 160.93%
Above Food Ingredients Inc. (ABVE:NASDAQ), 134.19%
Signing Day Sports, Inc. (SGN:NYSEMKT), 93.5%
Boqii Holding Limited (BQ:NYSEMKT), 89.39%
Autozi Internet Technology (Global) Ltd. (AZI:NASDAQ), 78.03%
Newegg Commerce, Inc. (NEGG:NASDAQ), 71.39%
Zepp Health Corporation (ZEPP:NYSE), 69.46%